Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[While patients with ECE-1 overexpressing tumours had more frequent disease recurrence (P = 0.03), NEP overexpression correlated with improved disease-free survival (DFS) (P = 0.023) and less frequent metastasis (P = 0.046).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP935783.RAs6To5mPpHeVsvdCVUeMA5m2KPXWtWisfvnXgv3eeNNo130_assertion description "[While patients with ECE-1 overexpressing tumours had more frequent disease recurrence (P = 0.03), NEP overexpression correlated with improved disease-free survival (DFS) (P = 0.023) and less frequent metastasis (P = 0.046).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP935783.RAs6To5mPpHeVsvdCVUeMA5m2KPXWtWisfvnXgv3eeNNo130_provenance.
• assertion description "[While patients with ECE-1 overexpressing tumours had more frequent disease recurrence (P = 0.03), NEP overexpression correlated with improved disease-free survival (DFS) (P = 0.023) and less frequent metastasis (P = 0.046).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP565802.RA9Vr6sJyI5ZX2LB4j55LfvtrqC0DBWFhas6vTav65USI130_assertion description "[While patients with ECE-1 overexpressing tumours had more frequent disease recurrence (P = 0.03), NEP overexpression correlated with improved disease-free survival (DFS) (P = 0.023) and less frequent metastasis (P = 0.046).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP565802.RA9Vr6sJyI5ZX2LB4j55LfvtrqC0DBWFhas6vTav65USI130_provenance.
• NP560080.RAZ3aac-Qj6frz6xgxGETJa9k13_l8TcetMgUkgJrkwJU130_assertion description "[While patients with ECE-1 overexpressing tumours had more frequent disease recurrence (P = 0.03), NEP overexpression correlated with improved disease-free survival (DFS) (P = 0.023) and less frequent metastasis (P = 0.046).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP560080.RAZ3aac-Qj6frz6xgxGETJa9k13_l8TcetMgUkgJrkwJU130_provenance.
• NP560307.RAev6ej7s39VRWr4jkkPLqibF3CR-zksAenE09uAg7arM130_assertion description "[While patients with ECE-1 overexpressing tumours had more frequent disease recurrence (P = 0.03), NEP overexpression correlated with improved disease-free survival (DFS) (P = 0.023) and less frequent metastasis (P = 0.046).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP560307.RAev6ej7s39VRWr4jkkPLqibF3CR-zksAenE09uAg7arM130_provenance.
• NP363787.RAel_LQbQr8PJsN7OxMwglHy-BBn9rewp9nIfWG0hFCHY130_assertion description "[While patients with ECE-1 overexpressing tumours had more frequent disease recurrence (P = 0.03), NEP overexpression correlated with improved disease-free survival (DFS) (P = 0.023) and less frequent metastasis (P = 0.046).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP363787.RAel_LQbQr8PJsN7OxMwglHy-BBn9rewp9nIfWG0hFCHY130_provenance.
• NP555950.RAHyiHOfyzkZW4N9j1-ylBq3QSOVi6yKi-GGaa87ae9GM130_assertion description "[While patients with ECE-1 overexpressing tumours had more frequent disease recurrence (P = 0.03), NEP overexpression correlated with improved disease-free survival (DFS) (P = 0.023) and less frequent metastasis (P = 0.046).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP555950.RAHyiHOfyzkZW4N9j1-ylBq3QSOVi6yKi-GGaa87ae9GM130_provenance.
• assertion description "[While patients with ECE-1 overexpressing tumours had more frequent disease recurrence (P = 0.03), NEP overexpression correlated with improved disease-free survival (DFS) (P = 0.023) and less frequent metastasis (P = 0.046).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP593372.RAX6uH0p9WeUCkwdkepxjgTkRY9NGBtly24Xjwee7Qh6E130_assertion description "[While patients with ECE-1 overexpressing tumours had more frequent disease recurrence (P = 0.03), NEP overexpression correlated with improved disease-free survival (DFS) (P = 0.023) and less frequent metastasis (P = 0.046).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP593372.RAX6uH0p9WeUCkwdkepxjgTkRY9NGBtly24Xjwee7Qh6E130_provenance.
• NP876049.RAKMaXfGcTgdh-V64bM6_Mc_8nITLVKhYG5sq4GnlHO60130_assertion description "[While patients with ECE-1 overexpressing tumours had more frequent disease recurrence (P = 0.03), NEP overexpression correlated with improved disease-free survival (DFS) (P = 0.023) and less frequent metastasis (P = 0.046).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP876049.RAKMaXfGcTgdh-V64bM6_Mc_8nITLVKhYG5sq4GnlHO60130_provenance.
• NP560358.RALAX0q0y4Jkx5_cgol7RnWE6EW5fR2midemDbGi3aLP4130_assertion description "[While patients with ECE-1 overexpressing tumours had more frequent disease recurrence (P = 0.03), NEP overexpression correlated with improved disease-free survival (DFS) (P = 0.023) and less frequent metastasis (P = 0.046).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP560358.RALAX0q0y4Jkx5_cgol7RnWE6EW5fR2midemDbGi3aLP4130_provenance.
• NP363819.RA6a1rowlNCbBh92nrte1FV0rTHJWRDR3folZ8T8wiDQA130_assertion description "[While patients with ECE-1 overexpressing tumours had more frequent disease recurrence (P = 0.03), NEP overexpression correlated with improved disease-free survival (DFS) (P = 0.023) and less frequent metastasis (P = 0.046).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP363819.RA6a1rowlNCbBh92nrte1FV0rTHJWRDR3folZ8T8wiDQA130_provenance.
• NP363825.RAPHi_Jpb04IhNmR-i0blEKc8veHjlOoJGV5tfQjl2EPY130_assertion description "[While patients with ECE-1 overexpressing tumours had more frequent disease recurrence (P = 0.03), NEP overexpression correlated with improved disease-free survival (DFS) (P = 0.023) and less frequent metastasis (P = 0.046).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP363825.RAPHi_Jpb04IhNmR-i0blEKc8veHjlOoJGV5tfQjl2EPY130_provenance.
• NP593369.RAKPlQoQpAL4gESaIbvR6MwW5wUIlTmATFiCp9zpiNqkk130_assertion description "[While patients with ECE-1 overexpressing tumours had more frequent disease recurrence (P = 0.03), NEP overexpression correlated with improved disease-free survival (DFS) (P = 0.023) and less frequent metastasis (P = 0.046).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP593369.RAKPlQoQpAL4gESaIbvR6MwW5wUIlTmATFiCp9zpiNqkk130_provenance.